This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Iterion Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Garry Gwozdz: Innovator in Pharmaceutical Formulations
Introduction
Garry Gwozdz is a notable inventor based in Jim Thorpe, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly with his work on tegavivint and related compounds. His innovative approach has the potential to impact various medical conditions.
Latest Patents
Garry Gwozdz holds a patent for "Formulations of tegavivint and related compounds." This patent encompasses formulations, methods of making such formulations, and methods of treating various conditions utilizing these formulations. His work in this area demonstrates a commitment to advancing therapeutic options.
Career Highlights
Garry is associated with Iterion Therapeutics, Inc., where he applies his expertise in pharmaceutical development. His role at the company allows him to collaborate with other professionals in the field, enhancing the potential for innovative breakthroughs.
Collaborations
Garry has worked alongside notable colleagues such as Steven David Dykstra and Henry Havel. These collaborations contribute to a dynamic environment that fosters creativity and innovation in pharmaceutical research.
Conclusion
Garry Gwozdz is a dedicated inventor whose work in pharmaceutical formulations is paving the way for new treatment options. His contributions are significant in the ongoing quest for medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile